Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Mothaffar Rimawi
With
We want to determine the effects of Herceptin and to determine its efficacy in women with HER-2 overexpressing advanced breast cancer. The end-points will include the comparison of an array of histologic and molecular markers from sequential core biopsies of primary breast cancers of patients receiving Herceptin. The other aim of this study would be to determine clinical response to therapy with Herceptin and Taxotere.
Age
18–90
Sex
FEMALE
Healthy volunteers
Not accepted